Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2019

Open Access 01-12-2019 | Colorectal Cancer | Research article

Geographical patterns of the incidence and mortality of colorectal cancer in mainland Portugal municipalities (2007–2011)

Authors: R. Roquette, M. Painho, B. Nunes

Published in: BMC Cancer | Issue 1/2019

Login to get access

Abstract

Background

Cancer is a leading cause of morbidity and mortality in the world. In Portugal, colorectal cancer is one of the most incident cancers; thus, it is crucial to act to fight it. Knowledge of the geographical distribution of the incidence and mortality of colorectal cancer can facilitate the execution of these actions and make them more effective.

Methods

Our paper aims to describe and discuss the geographical patterns of colorectal cancer incidence and mortality in mainland Portugal municipalities (2007–2011). We used the Besag, York and Mollié (BYM) model to compute the relative risk (RR) and posterior probability (PP). We performed a cluster analysis with Global Moran’s Index and Local Moran’s Index (LISA). We ran a geographically weighted regression (GWR) to compare incidence and mortality patterns.

Results

Incidence and mortality have different distributions of RR values. The interval of RR concerning incidence was higher than the interval of RR concerning mortality. PP values reinforce the finding of higher heterogeneity of the incidence of colorectal cancer.

The comparison of the cluster maps for incidence and mortality shows a few municipalities classified with the same cluster type in both maps. Additionally, the GWR results show that the percentage of RR mortality explained by RR incidence differs throughout mainland Portugal.

From the comparison of our results with the prevalence of risk factors (at NUTS II level), the need to be aware of smoking habits, alcohol consumption and the unhealthy diet of the Portuguese population stands out.

Conclusions

There are differences in the geographical distribution of the RR incidence and RR mortality of colorectal cancer in mainland Portugal municipalities. Likewise, it is relevant to highlight the cluster of two municipalities with high RR values concerning colorectal cancer’s incidence and mortality. Future research is necessary to explain the geographical differences in the distribution of colorectal cancer in mainland Portugal municipalities. Based on our findings, it may be interesting to examine the influence of smoking, alcohol consumption, diet and screening on colorectal cancer in greater detail. Additionally, it may be relevant to develop an analysis focused on municipalities where the incidence values explain the mortality values poorly (or well).

Literature
  1. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JWW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer. 2008;44:1345–89.View Article
  2. Cotter J. Colorectal cancer: Portugal and the world. Acta Medica Port. 2013;26:485–6.
  3. Bosetti C, Levi F, Rosato V, Bertuccio P, Lucchini F, Negri E, La Vecchia C. Recent trends in colorectal cancer mortality in Europe. Int J Cancer. 2011;129:180–91.View Article
  4. Pinheiro P, Tyczynski J, Bray F, Amado J, Matos E, Miranda A, Limbert E. Cancer in Portugal. In: IARC, editor. IARC technical publication no 38. France, IARC, 2002. p. 72.
  5. Pinto CG, Paquete AT, Pissarra I. Colorectal cancer in Portugal. Eur J Health Econ. 2010;10:65.View Article
  6. Miranda N, Portugal C, Nogueira PJ, Farinha CS, Oliveira AL, Alves MI, Martins J. Portugal Doenças Oncológicas em números, 2015, Portugal Doenças Oncológicas em números, 2015; 2016. p. 7–65.
  7. NCI dictionary of cancer terms [https://​www.​cancer.​gov/​publications/​dictionaries/​cancer-terms?​expand=​L], Accessed 30 Oct 2017.
  8. Nadler DL, Zurbenko IG. Estimating cancer latency times using a Weibull model. Advances in Epidemiology. 2014;2014:8. Article ID 746769.View Article
  9. IARC: List of classification by cancer sites with sufficuent or limited evidence in humans, volumes 1 to 120. France: IARC; 2017.
  10. NIH. Cancer and the environment. USA: NIH; 2017.
  11. Lock K, Pomerleau J, Causer L, McKee M. Low fruit and vegetable consumption. In: Ezzati M, Lopez AD, Rodgers A, Murray CJ, editors. Comparative quantification of health risks. Global and regional burden of disease attributable to selected major risk factors. Geneva: World Health Organization; 2004. p. 597-728.
  12. Carta Administrativa Oficial de Portugal (CAOP) Versão 2009. http://​www.​dgterritorio.​pt/​dados_​abertos/​caop/​. Accessed 15 May 2017.
  13. Decreto Lei 46/89 de 15 de Fevereiro In Diário da república n°38/89, I série. Lisboa: Ministério do Planeamento e da Administração do Território; 1989.
  14. RORENO [http://​www.​roreno.​com.​pt/​]. Accessed 30 Oct 2017.
  15. ROR Centro [https://​ipocoimbra.​com/​ror/​]. Accessed 30 Oct 2017.
  16. ROR Sul [https://​ron.​min-saude.​pt/​pt/​]. Accessed 30 Oct 2017.
  17. Statistics Portugal [https://​ine.​pt/​xportal/​xmain?​xpgid=​ine_​main&​xpid=​INE]. Accessed 30 Oct 2017.
  18. WHO. International statistical classification of diseases and related health problems - 10th revision. Geneve: World Health Organization; 2016.
  19. Jensen OM. Cancer registration: principles and methods. France: IARC; 1991.
  20. Besag J, York J, Mollié A. Bayesian image restoration, with two applications in spatial statistics. Ann Inst Stat Math. 1991;43:1–20.View Article
  21. Rue H, Martino S, Chopin N. Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations. J R Stat Soc Ser B Stat Methodol. 2009;71:319–92.View Article
  22. Blangiardo M, Cameletti M. Spatial and spatio-temporal Bayesian models with R-INLA. United Kingdom: Wiley; 2015.View Article
  23. Roquette R, Nunes B, Painho M. The relevance of spatial aggregation level and of applied methods in the analysis of geographical distribution of cancer mortality in mainland Portugal (2009–2013). Popul Health Metrics. 2018;16:6.View Article
  24. Lopez-Abente G, Aragones N, Perez-Gomez B, Pollan M, Garcia-Perez J, Ramis R, Fernandez-Navarro P. Time trends in municipal distribution patterns of cancer mortality in Spain. BMC Cancer. 2014;14:535.View Article
  25. Mota L, Falcão J. 2° Atlas da mortalidade por cancro em Portugal 1990–1992. Lisboa: Departamento de Estudos e Planeamento da Saúde; 1997.
  26. ArcGIS [https://​www.​arcgis.​com/​features/​index.​html], Accessed 10 Mar 2018.
  27. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102:605–13.View Article
  28. DGS. Programa Nacional para as Doenças Oncológicas. Avaliação e Monitorização dos Rastreios Oncológicos Organizados de Base Populacional de Portugal. Relatório, vol. 2015. Lisboa: Direcção Geral de Saúde; 2016.
  29. Saib M-S, Caudeville J, Carre F, Ganry O, Trugeon A, Cicolella A. Spatial relationship quantification between environmental, socioeconomic and health data at different geographic levels. Int J Environ Res Public Health. 2014;11:3765–86.View Article
  30. Lagiou P, Trichopoulou A, Trichopoulos D. Nutritional epidemiology of cancer: accomplishments and prospects. Proc Nutr Soc. 2002;61:217–22.View Article
  31. INSA/INE. Inquérito Nacional de Saúde 2005/2006. Lisboa: INSA, INE; 2009.
  32. Zhao J, Zhu Y, Wang PP, West R, Buehler S, Sun Z, Squires J, Roebothan B, McLaughlin JR, Campbell PT. Interaction between alcohol drinking and obesity in relation to colorectal cancer risk: a case-control study in Newfoundland and Labrador, Canada. BMC Public Health. 2012;12:94.View Article
  33. Stewart BW, Kleihues P. World cancer report. France: IARC; 2003.
  34. INSA: 1° Inquérito Nacional de Saúde com Exame Físico (INSEF 2015): Determinantes de Saúde. Lisboa: Instituto Nacional de Saúde Doutor Ricardo Jorge, IP; 2017.
  35. Magalhães B, Bastos J, Lunet N. Dietary patterns and colorectal cancer: a case–control study from Portugal. Eur J Cancer Prev. 2011;20:389–95.View Article
  36. Rougier P, Mitry E. Epidemiology, treatment and chemoprevention in colorectal cancer. Ann Oncol. 2003;14:ii3–5.View Article
  37. Ott JJ, Ullrich A, Mascarenhas M, Stevens GA. Global cancer incidence and mortality caused by behavior and infection. J Public Health. 2011;33:223–33.View Article
  38. Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M. Group CRAc: causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005;366:1784–93.View Article
Metadata
Title
Geographical patterns of the incidence and mortality of colorectal cancer in mainland Portugal municipalities (2007–2011)
Authors
R. Roquette
M. Painho
B. Nunes
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2019
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-019-5719-9

Other articles of this Issue 1/2019

BMC Cancer 1/2019 Go to the issue

Research article

Fast-track multidisciplinary treatment versus conventional treatment for colorectal cancer: a multicenter, open-label randomized controlled study

Research article

Silencing of long-non-coding RNA ANCR suppresses the migration and invasion of osteosarcoma cells by activating the p38MAPK signalling pathway

Research article

Flemish breast cancer screening programme: 15 years of key performance indicators (2002–2016)

Research article

An analysis about heterogeneity among cancers based on the DNA methylation patterns

Research article

Geographical disparities in treatment and health care costs for end-of-life cancer patients in China: a retrospective study

Correction

Correction to: A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits